ArticlemedRxiv : the preprint server for health sciences2025
Mapping Chemical-Gene Interactions for Developmental Lethality and Pregnancy Loss.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Purpose: Pregnancy loss affects 10-15% of clinically recognized pregnancies and is driven by genetic and environmental factors. Interactions between genes and chemicals critically shape developmental outcomes, yet existing resources do not organize chemical-gene evidence by gestational timing, maternal-fetal compartment, or lethality context. Methods: To minimize this gap, we merged Intolerome genes and the Comparative Toxicogenomics Database databases to create a filtered network of 928 lethality-associated genes and ~4,000 chemicals. We developed the Chemical-Gene Atlas (CGA) application, which analyzes chemical-gene interactions using four filters supporting hypothesis generation and clinical translation. Results: Using recurrent pregnancy loss (RPL) as a case study, CGA identified five clinically important genes (F5, F2, AURKB, PADI6, and FOXD1) demonstrating different exposomic patterns with Bisphenol A (BPA) and Benzo[a]pyrene (B[a]P). These exposures affect gene expression, methylation, and coagulation pathways and placental function. Our findings demonstrate that genes with loss-of-function intolerance, especially those expressed in metabolic and cardiovascular systems, are susceptible to environmental disruption during critical windows of development, including implantation, placental development, and early organogenesis. Conclusion: The CGA platform provides a scalable model to investigate chemical-gene interactions leading to developmental lethality. CGA is available at https://cgatlas.org/.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.